Anti-Lujo virus/LUJV Matrix Polyclonal Antibody from ProteoGenix; catalogue ARO-A22394; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Product: Anti-Lujo virus/LUJV Matrix Polyclonal Antibody
The Anti-Lujo virus/LUJV Matrix Polyclonal Antibody is a highly specific and sensitive antibody designed to target the Matrix protein of the Lujo virus (LUJV). The Matrix protein is a key component of the LUJV, a highly pathogenic virus that belongs to the Arenaviridae family. This antibody binds to the Matrix protein, preventing its interaction with host cells and inhibiting viral replication.
This antibody is essential for research on LUJV and its potential as a bioterrorism agent. It is also a valuable tool for studying the pathogenesis of LUJV and developing effective treatments and vaccines. In addition, this antibody can be used for diagnostic purposes, such as detecting the presence of LUJV in patient samples.
The Anti-Lujo virus/LUJV Matrix Polyclonal Antibody has been extensively tested in various experimental settings, including immunofluorescence, Western blotting, and immunohistochemistry. In immunofluorescence assays, this antibody has shown high specificity and sensitivity in detecting LUJV-infected cells. In Western blotting, it has successfully identified the Matrix protein in LUJV-infected cell lysates. In immunohistochemistry, this antibody has been used to detect LUJV in tissue samples, providing valuable insights into the virus’s tissue tropism and pathogenesis.
Keywords: Anti-Lujo virus/LUJV Matrix Polyclonal Antibody, biological function, main applications, experimental use cases, LUJV, Arenaviridae, Matrix protein, bioterrorism agent, pathogenesis, treatments, vaccines, diagnostic, immunofluorescence, Western blotting, immunohistochemistry, specificity, sensitivity, tissue tropism.
ProteoGenix catalogue number ARO-A22394. For research use only.
Target: multifunctional matrix-like protein, multifunctional matrix-like protein; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| multifunctional matrix-like protein, multifunctional matrix-like protein |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
